Q2 2025 CRO Activity and Intel Report

Description

This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q2 2025.

Scope

The Q2 CRO Activity and Intel report offers insights into CRO and sponsor activity, clinical trial trends, and geographical performance across various therapeutic areas.

Reasons to Buy

This report will enable the user to answer the following questions -

What are the trends by region, therapy area, sites by CROs for the past quarter?
Who was the most active CRO in the past quarter?
Who were the most active sponsors by market cap in the past quarter?
What was the most widely studied therapy area in the past quarter vs. the previous year's quarter?
By region, who had the most clinical trials initiated in the past quarter?
By region, what were the past quarter's CRO invitations and appointments?

Product Code: GDHCO95CRO

Introduction
Global
CRO and sponsor activity in Q2 2025
Most-used CROs
Most active large- and mega-cap sponsors
Most active mid-cap sponsors
Most active small-cap sponsors
Clinical trials in oncology and CNS
Therapeutic area breakdown of clinical trials initiated in Q2 2025 vs. Q2 2024
Trials initiated in the 10 most active oncology indications in Q2 2025 vs. Q2 2024
Trials initiated in the 10 most active CNS indications in Q2 2025 vs. Q2 2024
Top 10 CROs by number of sites in Q2 2025
North America
Clinical trial activity in North America in Q2 2025
Most active North American regions in Q2 2025 vs. Q2 2024
Phase breakdown of trials initiated in North America in Q2 2025 vs. Q2 2024
Therapeutic area breakdown of clinical trials initiated in North America in Q2 2025 vs. Q2 2024
Top 10 trial sites by trials initiated in North America in Q2 2025
Insights: CRO invites for sponsors based in North America
Europe
Clinical trial activity in Europe in Q2 2025
Most active European regions in Q2 2025 vs. Q2 2024
Phase breakdown of trials initiated in Europe in Q2 2025 vs. Q2 2024
Therapeutic area breakdown of clinical trials initiated in Europe in Q2 2025 vs. Q2 2024
Top 10 trial sites by trials initiated in Europe in Q2 2025
Insights: CRO invites for sponsors based in Europe
Rest of the world
Clinical trial activity in ROW in Q2 2025
Most active regions in ROW in Q2 2025 vs. Q2 2024
Phase breakdown of trials initiated in ROW in Q2 2025 vs. Q2 2024
Therapeutic area breakdown of clinical trials initiated in ROW in Q2 2025 vs. Q2 2024
Top 10 trial sites by trials initiated in ROW in Q2 2025
Insights: CRO invites for sponsors based in ROW

Q2 2025 CRO Activity and Intel Report

Description

Table of Contents

Scope

Reasons to Buy

Table of Contents

Table of Contents

Appendix